VCM
CLB icon

Virtue Capital Management’s Core Laboratories CLB Stock Holding History

Virtue Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3
Closed – – 549
2017
Q4 		$0 Buy
+3
New +$299 ﹤0.01% 465

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Virtue Capital Management's CLB Position: Q1 2018 in Review

Virtue Capital Management sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 3 shares.

Virtue Capital Management first reported a position in CLB in Q4 2017 and held it in 1 quarter. The position peaked at $0 in Q4 2017. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

  • Virtue Capital Management reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
  • Virtue Capital Management sold 3 Core Laboratories shares in Q1 2018.
  • Virtue Capital Management first reported a position in Core Laboratories in Q4 2017 and held it in 1 quarter.
  • Virtue Capital Management's Core Laboratories position peaked at $0 in Q4 2017.
  • 355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Virtue Capital Management's 13F filing for Q1 2018, filed 15 May 2018.